Deciphering Persistent Orofacial Pain - PIFP
1 other identifier
observational
60
1 country
1
Brief Summary
Persistent non-dental orofacial pain is common yet poorly characterised, and its pathophysiology remains largely unknown. Two clinically similar entities are distinguished: post-traumatic trigeminal neuropathic pain (PTNP), in which peripheral nerve damage is demonstrable, and persistent idiopathic facial pain (PIFP), in which peripheral findings are typically absent - pointing to an altered central processing of trigeminal nociceptive input. This monocentric study characterises the peripheral and central mechanisms of PIFP by comparing PIFP patients with age- and sex-matched healthy controls using a combination of non-invasive peripheral and central approaches. The study comprises two work packages. The peripheral work package uses quantitative sensory testing (standardised DFNS protocol) to test the hypothesis that PIFP patients retain an intact peripheral nervous system. The central work package uses functional MRI with standardised trigemino-nociceptive stimulation to characterise brainstem network dynamics, testing the hypothesis that PIFP patients exhibit a central trigeminal processing disturbance at the brainstem level. In PIFP patients, the functional MRI is repeated before and after a local-anaesthetic nerve block in the pain area, additionally distinguishing patients whose pain is completely abolished by the block from those with persistent pain despite it. The overarching aim is to characterise the pathophysiological basis of PIFP and thereby advance the mechanistic understanding of persistent orofacial pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2029
Study Completion
Last participant's last visit for all outcomes
October 31, 2029
August 27, 2026
August 1, 2026
2.8 years
August 18, 2026
August 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Difference in brain functional neuroimaging response to standardized trigemino-nociceptive stimulation between PIFP patients HC
BOLD signal change (contrast estimates, arbitrary units) during standardized trigemino-nociceptive stimulation versus baseline, compared between PIFP patients and HC in a priori defined regions of interest and at whole-brain level.
Baseline (MRI session before local anesthesia)
Difference in brain activation before versus after the local-anesthetic nerve block, and between complete responders and non-responders
BOLD signal change (contrast estimates, arbitrary units) during standardized trigemino-nociceptive stimulation, compared within participants before versus after the local-anesthetic nerve block, and between participants whose pain is completely abolished by the block and those with persistent pain despite the block
Pre-block MRI at baseline and post-block MRI, both on the same day 1
Secondary Outcomes (1)
Comparison of deep phenotyping and quantitative sensory testing (QST) parameters between the study cohorts (PIFP versus HC).
Baseline (single assessment before local anesthesia)
Study Arms (2)
Patients with persistent idiopathic facial pain (PIFP)
Patients with persistent idiopathic facial pain
Age- and sex-matched healthy controls (HC)
Eligibility Criteria
Patients with PIFP will be recruited from the headache/facial pain outpatient clinic of the University Medical Center Hamburg-Eppendorf
You may qualify if:
- Healthy controls: written informed consent.
- PIFP cohort: written informed consent, and a diagnosis of PIFP according to the ICHD-3 and ICOP diagnostic criteria.
You may not qualify if:
- Contraindication to MR scanning
- Anxiety disorders, including claustrophobia
- Other somatic diseases, including other pain disorders
- Other primary headache disorders and medication-overuse headache
- Skin lesion , infection, or scarring at the stimulation sites preventing safe electrode placement
- Healthy volunteers: any history of persistent pain or primary headache, including in first-degree relatives
- History of psychiatric disease and/or addiction
- Pregnancy or lactation
- Any regular medication; in PIFP patients, occasional acute analgesic use (NSAID, fewer than 8 days per month) is permitted
- Use of acute analgesic within 24 hours before the experiment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Hamburg-Eppendorf
Hamburg, 20246, Germany
Related Publications (3)
Ziegeler C, Schulte LH, May A. Altered trigeminal pain processing on brainstem level in persistent idiopathic facial pain. Pain. 2021 May 1;162(5):1374-1378. doi: 10.1097/j.pain.0000000000002126.
PMID: 33110030BACKGROUNDMehnert J, Basedau H, Sturm LM, Nielsen T, Jensen RH, May A. Functional brainstem representations of the human trigeminal cervical complex. Cephalalgia. 2023 May;43(5):3331024231174862. doi: 10.1177/03331024231174862.
PMID: 37203351BACKGROUNDMay A, Ciancia V, Basedau H. Visualizing nociplastic pain: functional hyperexcitability in neuropathic and idiopathic facial pain syndromes. J Headache Pain. 2025 Oct 13;26(1):211. doi: 10.1186/s10194-025-02133-w.
PMID: 41083924BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Arne May, MD, PhD
Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate
Study Record Dates
First Submitted
August 18, 2026
First Posted
August 27, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
June 30, 2029
Study Completion (Estimated)
October 31, 2029
Last Updated
August 27, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared with other researchers. Data are collected and analyzed in pseudonymized form, and results will be reported and published only in aggregated, anonymized form that does not permit identification of individual participants. The pseudonymization key is held exclusively by the study leadership and is deleted as soon as the research purpose allows. Consistent with the informed consent obtained from participants and the approved data protection concept, no de-identified individual-level datasets will be made available externally.